Literature DB >> 5973632

[Monoamine oxidase inhibition by beta-adrenolytic substances].

K Greeff, J Wagner.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5973632     DOI： 10.1007/bf00591808

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  5 in total

1.  INHIBITION OF SYMPATHOMIMETIC EFFECTS ON THE HEART.

Authors:  B G BENFEY; D R VARMA
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS.

Authors:  A MORALES AGUILERA; E M VAUGHANWILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).

Authors:  J W BLACK; J S STEPHENSON
Journal:  Lancet       Date:  1962-08-18       Impact factor: 79.321

4.  An analysis of adrenergic blocking activity.

Authors:  B LEVY; R P AHLQUIST
Journal:  J Pharmacol Exp Ther       Date:  1961-08       Impact factor: 4.030

5.  [Influence of aminoxydase inhibition on the effects of biogenic amines].

Authors:  H BALZER; P HOLTZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956
  5 in total
  2 in total

1.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.